Xconomy

APRIL 18, 2017

Following a six-month trial of its digital mortgage platform, San Diego-based Approved has officially launched its Web-based software for home loan applications. Sadhal and Taylor (pictured above) founded Approved in August 2015, and moved into the San Diego tech incubator.

Platform 79

Platform San Diego Incubator Web 79

Xconomy

NOVEMBER 13, 2016

View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. The results were so encouraging, we’re doing it again. Financial terms were not disclosed. Webroot withheld terms of the deal.).

San Diego 40

San Diego Technical Review Artificial Inteligence Startup 40

Xconomy

MARCH 19, 2017

After the adhesive products maker Avery Dennison (NYSE: AVY ) recently made a $3 million investment in San Diego-based Wrapify , we tracked down Wrapify CEO James Heller, and stuck him with a few questions about the deal.

Advertising 45

Advertising Glendale San Diego Incubator 45

socalTECH

MARCH 11, 2016

What do you get when you combine a charitable pub crawl, the movie Anchorman, and a software developer randomly hired off Craigslist? In the case of San Diego's Classy (www.classy.org), you get an extremely popular piece of software-as-a-service to help you manage a nonprofit and its fundraising efforts.

Help 100

Help San Diego Organization Startup 100

Xconomy

OCTOBER 14, 2016

. —Shares of San Diego-based Illumina (NASDAQ: ILMN ) fell more than 32 percent after the next-gen sequencing giant slashed its revenue projections once again. in July 2015. —AzurRx Biopharma (NASDAQ: AZRX ), which has an executive office at SUNY Downstate’s biotech incubator in Brooklyn, raised $5.3

News 40

News San Diego Incubator Research 40

Xconomy

JUNE 3, 2016

—A team led by Jef Boeke of New York University, George Church of Harvard University, Andrew Hessel of software maker Autodesk, and Nancy Kelley proposed in the journal Science to build a synthetic human genome. AstraZeneca got the drug when it bought ZS Pharma in late 2015 for $2.7 Teva nabbed deutetrabenazine in its $3.2

San Diego 62

San Diego Patents Acquisition News 62